David A. Lipson
GlaxoSmithKline (United States)
ORCID: 0000-0001-6732-4593Also affiliated with University of Pennsylvania
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials”.
Nicola J. Brown, Chris Compton, Thomas Corbridge, Kelly Dorais, Charles Fogarty +9 more
Astrid Yeo, Joshua Hoffman, Mathias Chiano, Dana J. Fraser, Soumitra Ghosh +6 more
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial
Gerard J. Criner, David Halpin, MeiLan K. Han, Renu Jain, Peter Lange +6 more
David Halpin, MeiLan K. Han, Nicola A. Hanania, Ravi Kalhan, David A. Lipson +7 more